Expected continuation of ADT for \>6 months upon initiation of study procedures
Serum testosterone \<50 ng/dL
BMI \>25
Age \>18 years old
African American and Non-Hispanic white males
Subjects must read and sign the Institutional Review Board-approved written informed consent prior to the initiation of any study specific procedures or enrollment. A subject will be excluded for any condition that might compromise the ability to give truly informed consent
You may not be if
Life expectancy \< 1 year
Females
Radiation or chemotherapy treatment
History of diabetes or serious medical condition including uncontrolled hypertension, liver, kidney, and cardiovascular disease
Any subject with a screening laboratory value outside of the laboratory normal range that is considered clinically significant for study participation by the investigator
Any subject who currently uses tobacco products
Any use of \>20 g of alcohol per day
Any subject who is unable or unwilling to comply with the study protocol
